Literature DB >> 27737791

A novel synthetic cathinone, 2-(methylamino)-1-(naphthalen-2-yl) propan-1-one (BMAPN), produced rewarding effects and altered striatal dopamine-related gene expression in mice.

Chrislean Jun Botanas1, Seong Shoon Yoon2, June Bryan de la Peña1, Irene Joy Dela Peña1, Mikyung Kim1, Taeseon Woo1, Joung-Wook Seo2, Choon-Gon Jang3, Kyung-Tae Park4, Young Hun Lee4, Yong Sup Lee4, Hee Jin Kim5, Jae Hoon Cheong6.   

Abstract

The recreational use of synthetic cathinones has grown rapidly which prompted concerns from legal authorities and health care providers. However, in response to legislative regulations, synthesis of novel synthetic cathinones by introducing substituents in cathinone molecule has dramatically increased the diversity of these substances. Based on current trends, the aromatic ring is one of the popular sites in cathinone molecule being explored by designer-type modifications. In this study, we designed and synthesized a novel synthetic cathinone, 2-(methylamino)-1-(naphthalen-2-yl) propan-1-one (BMAPN), which has a naphthalene substituent on the aromatic ring. Thereafter, we determined whether BMAPN has rewarding and reinforcing effects through the conditioned place preference (CPP) test in mice and self-administration (SA) paradigm in rats. Locomotor sensitization was also assessed in mice during daily BMAPN treatment for 7days and drug challenge. Furthermore, we investigated the effects on BMAPN on dopamine-related genes in the striatum of mice using quantitative real-time polymerase chain reaction (qRT-PCR). BMAPN induced CPP at 10 and 30mg/kg and was modestly self-administered at 0.3mg/kg/infusion. Repeated BMAPN (30mg/kg) administration also produced locomotor sensitization. qRT-PCR analyses revealed decreased dopamine transporter and increased dopamine receptor D2 gene expression in the striatum of the BMAPN-treated mice. These data indicate that BMAPN has rewarding and reinforcing properties, which might be due to its effects on dopamine-related genes. The present study suggests that these findings may be useful in predicting abuse potential of future cathinone entities with aromatic ring substitutions.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Abuse potential; Conditioned place preference; Locomotor sensitization; Self-administration; Synthetic cathinones

Mesh:

Substances:

Year:  2016        PMID: 27737791     DOI: 10.1016/j.bbr.2016.10.016

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  5 in total

1.  The dopamine, serotonin and norepinephrine releasing activities of a series of methcathinone analogs in male rat brain synaptosomes.

Authors:  Bruce E Blough; Ann M Decker; Antonio Landavazo; Ojas A Namjoshi; John S Partilla; Michael H Baumann; Richard B Rothman
Journal:  Psychopharmacology (Berl)       Date:  2018-10-20       Impact factor: 4.530

Review 2.  Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health.

Authors:  Aviv M Weinstein; Paola Rosca; Liana Fattore; Edythe D London
Journal:  Front Psychiatry       Date:  2017-08-23       Impact factor: 4.157

3.  The Abuse Potential of α-Piperidinopropiophenone (PIPP) and α-Piperidinopentiothiophenone (PIVT), Two New Synthetic Cathinones with Piperidine Ring Substituent.

Authors:  Chrislean Jun Botanas; Seong Shoon Yoon; June Bryan de la Peña; Irene Joy Dela Peña; Mikyung Kim; Taeseon Woo; Joung-Wook Seo; Choon-Gon Jang; Kyung-Tae Park; Young Hun Lee; Yong Sup Lee; Hee Jin Kim; Jae Hoon Cheong
Journal:  Biomol Ther (Seoul)       Date:  2017-03-01       Impact factor: 4.634

Review 4.  Synthetic Cathinones: Recent Developments, Enantioselectivity Studies and Enantioseparation Methods.

Authors:  Ana Sofia Almeida; Bárbara Silva; Paula Guedes de Pinho; Fernando Remião; Carla Fernandes
Journal:  Molecules       Date:  2022-03-22       Impact factor: 4.411

5.  Striatal miR-183-5p inhibits methamphetamine-induced locomotion by regulating glucocorticoid receptor signaling.

Authors:  Sang-Hoon Song; Won-Jun Jang; Eun Young Jang; Oc-Hee Kim; Haesoo Kim; Taekwon Son; Dong-Young Choi; Sooyeun Lee; Chul-Ho Jeong
Journal:  Front Pharmacol       Date:  2022-09-26       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.